A role for immune dysfunction has been suggested in autism spectrum disorders (ASD). Elevated levels of chemokines have been detected in the brain and CSF of individuals with ASD but, to date, no study has examined chemokine levels in the plasma of children with this disorder. In the current study, we determined whether there were differential profiles of chemokines in the plasma of children with ASD compared to agematched typically developing controls and children with developmental disabilities other than ASD. Increased MCP-1, RANTES and eotaxin levels were observed in ASD children compared with both control groups (p b 0.03), and increased chemokine production was associated with higher aberrant behavior scores and more impaired developmental and adaptive function.. Elevated MCP-1, RANTES and eotaxin in some ASD children and their association with more impaired behaviors may have etiological significance. Chemokines and their receptors might provide unique targets for future therapies in ASD.
Introduction
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders that manifest during early childhood and are characterized by stereotyped interests and impairments in social interaction and communication (APA, 2000) . Recent epidemiologic studies have suggested that ASD is diagnosed in approximately 1% of children (Kogan et al., 2009; MMWR, 2009) yet little is known about the etiology and underlying neuropathology, and there are no clear biological markers for these disorders. Evidence of immune dysfunction has been observed in many individuals with ASD, including marked activation of microglia, increased levels of proinflammatory cytokines in brain tissue, CSF and plasma, and increased production of cytokines by peripheral blood mononuclear cell (PBMC) cultures (Ashwood et al., 2008 (Ashwood et al., , 2009 (Ashwood et al., , 2010 Ashwood and Wakefield, 2006; Enstrom et al., 2009a; Enstrom et al., 2010; Jyonouchi et al., 2001; Molloy et al., 2005; Onore et al., 2009; Vargas et al., 2005; Zimmerman et al., 2005) .
Chemokines are a class of structurally similar proteins that are important in the development of lymphocytes, including their recruitment and trafficking to specific tissue compartments. In addition to acting as key chemotactic factors in the immune system, chemokines and their receptors play a pivotal role in dictating the movement of leukocytes into the CNS in both healthy and diseased individuals as illustrated in multiple sclerosis, Alzheimer's and Parkinson's disease (Mélik-Parsadaniantz and Rostène, 2008) . In ASD, levels of the chemokines macrophage chemoattractant MCP-1 and eotaxin were found to be elevated in astrocytes in the anterior cingulate gyrus, with pronounced elevation of MCP-1 also noted in the cerebellum and in brain tissue homogenates (Vargas et al., 2005) . A 12-fold increase in MCP-1 and eotaxin was also noted in CSF of ASD children when compared with controls (Vargas et al., 2005) . Expression of mRNA transcripts for the chemokines macrophage inflammatory protein (MIP)-1β and 10 kDa interferon-inducible protein IP-10 was elevated in the temporal cortex of ASD individuals (Garbett et al., 2008) , whereas gene expression of the chemokines MIP-1β and 'regulated upon activation normal T-cell expressed and secreted' (RANTES) were shown to be increased in the peripheral cells of ASD children (Enstrom et al., 2009a) . However, to date, no study has addressed whether protein levels of chemokines are increased in the sera or plasma of children with ASD.
To examine if there exists a differential profile for peripheral blood chemokine levels, we analyzed plasma chemokine levels in young children with a diagnosis of ASD, typically developing children, and children with developmental disabilities other than ASD who were frequency-matched for age. Moreover, plasma chemokine levels were Journal of Neuroimmunology 232 (2011) 196-199 
